DiscoverSCCM PodcastSCCM Pod-526 CCM: Alteplase Dosing in Pulmonary Embolism
SCCM Pod-526 CCM: Alteplase Dosing in Pulmonary Embolism

SCCM Pod-526 CCM: Alteplase Dosing in Pulmonary Embolism

Update: 2024-09-26
Share

Description

Host Samantha Gambles Farr, MSN, AG-ACNP, FNP-C, RNFA, is joined by Roman Melamed, MD, to discuss the comparative effectiveness of reduced-dose versus full-dose alteplase for acute pulmonary embolism, focusing on patient outcomes and complications. They will highlight study findings on significant improvements in hemodynamic and respiratory parameters in both groups, with a lower rate of hemorrhagic complications in the reduced-dose group (Melamed R, et al. Crit Care Med. 2024;52:72 9-742). Dr. Melamed is a critical care intensivist and director of the Pulmonary Embolism Program at Abbott Northwestern Hospital in Minneapolis, Minnesota, USA, and an adjunct associate professor at the University of Minnesota.
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

SCCM Pod-526 CCM: Alteplase Dosing in Pulmonary Embolism

SCCM Pod-526 CCM: Alteplase Dosing in Pulmonary Embolism

SCCM